Drug Profile
SYI 2074
Alternative Names: ALT-2074; BXT 51072; SYN-2074Latest Information Update: 08 Apr 2009
Price :
$50
*
At a glance
- Originator OXIS Therapeutics
- Developer OXIS Therapeutics; Synvista Therapeutics
- Class Anti-inflammatories; Anti-ischaemics; Organoselenium compounds; Small molecules
- Mechanism of Action Antioxidants; Cell adhesion molecule inhibitors; Glutathione peroxidase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Acute coronary syndromes; Asthma; Chronic obstructive pulmonary disease; Hepatitis; Plaque psoriasis; Respiratory distress syndrome; Septic shock; Ulcerative colitis